What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side, and pale yellowish-brown adhesive foil imprinted in black ink with Buprenorphinum 30 ug/h on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side, and pale yellowish-brown adhesive foil imprinted in black ink with Buprenorphinum 25 ug/h on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 20 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 20 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 10 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 15 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 5 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 5 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 20 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 10 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 10 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 5 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 15 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

BUPRENORPHINE SANDOZ patches are indicated for the management of severe pain where: · other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and · the pain is opioid-responsive, and · requires daily, continuous, long-term treatment. BUPRENORPHINE SANDOZ patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPRENORPHINE SANDOZ patches are not indicated as an as-needed (PRN) analgesia.

How to take it

The way to take this medicine is: Transdermal.

• Store below 25 degrees Celsius
• Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 15 micrograms/h" on upper side

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.